Caribou Biosciences, Inc.
NASDAQ:CRBU
0.9855 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 16.293 | 51.162 | 58.338 | 240.42 | 15.953 | 41.07 |
| Short Term Investments
| 193.244 | 277.665 | 189.325 | 135.412 | 0 | 8.401 |
| Cash and Short Term Investments
| 209.537 | 328.827 | 317.036 | 413.508 | 15.953 | 49.471 |
| Net Receivables
| 2.093 | 3.859 | 4.664 | 8.124 | 5.16 | 3.982 |
| Inventory
| 0 | 0 | -62.571 | -31.111 | 2.433 | 3.182 |
| Other Current Assets
| 7.747 | 6.155 | 7.921 | 7.236 | 3.193 | 3.555 |
| Total Current Assets
| 219.377 | 338.841 | 260.248 | 391.192 | 24.306 | 57.008 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 39.29 | 40.452 | 34.908 | 4.887 | 3.502 | 4.332 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | -10.503 | -2.847 | -2.484 | 0 |
| Long Term Investments
| 9.276 | 51.33 | 77.071 | 45.302 | 7.626 | 0 |
| Tax Assets
| 0 | 0 | 10.503 | 2.847 | 2.484 | 0 |
| Other Non-Current Assets
| 45.37 | 1.586 | 1.538 | 0.975 | 0.612 | 0.593 |
| Total Non-Current Assets
| 93.936 | 93.368 | 113.517 | 51.164 | 11.74 | 4.925 |
| Total Assets
| 313.313 | 432.209 | 373.765 | 442.356 | 36.046 | 61.933 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.476 | 3.12 | 1.146 | 3.99 | 2.601 | 2.537 |
| Short Term Debt
| 1.426 | 1.2 | 1.932 | 0 | 0.654 | 0.532 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0.005 | 0.011 |
| Deferred Revenue
| 3.129 | 2.847 | 9.937 | 8.703 | 0.161 | 0.717 |
| Other Current Liabilities
| 23.62 | 21.135 | 15.113 | 13.136 | 8.968 | 6.281 |
| Total Current Liabilities
| 30.651 | 28.302 | 28.128 | 25.829 | 12.389 | 10.078 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 25.061 | 25.908 | 26.78 | 0 | 0.924 | 0 |
| Deferred Revenue Non-Current
| 0 | 6.102 | 15.954 | 22.032 | 0.937 | 0.986 |
| Deferred Tax Liabilities Non-Current
| 0.548 | 0.557 | 0.381 | 0.476 | 0.155 | 0.65 |
| Other Non-Current Liabilities
| 4.102 | 2.939 | 1.651 | 6.194 | 45.078 | 42.756 |
| Total Non-Current Liabilities
| 29.711 | 35.506 | 44.766 | 28.702 | 47.094 | 44.392 |
| Total Liabilities
| 60.362 | 63.808 | 72.894 | 54.531 | 59.483 | 54.47 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 442.356 | 41.323 | 41.323 |
| Common Stock
| 0.009 | 0.008 | 0.006 | 0.006 | 0.001 | 0.001 |
| Retained Earnings
| -448.39 | -299.285 | -197.215 | -97.794 | -30.871 | 3.437 |
| Accumulated Other Comprehensive Income/Loss
| 0.255 | 0.03 | -1.518 | -0.135 | -0 | -0 |
| Other Total Stockholders Equity
| 701.077 | 667.648 | 499.598 | 485.748 | -33.89 | -37.298 |
| Total Shareholders Equity
| 252.951 | 368.401 | 300.871 | 387.825 | -23.437 | 7.463 |
| Total Equity
| 252.951 | 368.401 | 300.871 | 387.825 | -23.437 | 7.463 |
| Total Liabilities & Shareholders Equity
| 313.313 | 432.209 | 373.765 | 442.356 | 36.046 | 61.933 |